View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Dana Inc: 1 director

A director at Dana Inc sold 4,357 shares at 14.010USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

Lennar Corp: 1 director

A director at Lennar Corp sold 10,000 shares at 170.110USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

Copart Reports Third Quarter Fiscal 2024 Financial Results

DALLAS--(BUSINESS WIRE)-- Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended April 30, 2024. For the three months ended April 30, 2024, revenue, gross profit, and net income attributable to Copart, Inc. were $1.13 billion, $525.5 million, and $382.3 million, respectively. These represent an increase in revenue of $105.4 million, or 10.3%; an increase in gross profit of $42.1 million, or 8.7%; and an increase in net income attributable to Copart, Inc. of $31.9 million, or 9.1%, respectively, from the same period last year. Fully diluted earnings per share for t...

Comfort Systems Usa Inc: 1 director

A director at Comfort Systems Usa Inc gave away/sold 1,597 shares at 0.000USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

Winnebago Industries Board of Directors Approves Quarterly Cash Divide...

Winnebago Industries Board of Directors Approves Quarterly Cash Dividend Winnebago Industries has paid a quarterly dividend for 40 consecutive quarters EDEN PRAIRIE, Minn., May 15, 2024 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE:WGO), a leading outdoor lifestyle product manufacturer, today announced that the company’s Board of Directors approved a quarterly cash dividend of $0.31 per share payable on June 26, 2024, to common stockholders of record at the close of business on June 12, 2024. With this announcement, Winnebago Industries has paid a quarterly cash dividend to comm...

 PRESS RELEASE

Grand Design RV is Giving Away a Summer of Free Camping

Grand Design RV is Giving Away a Summer of Free Camping Winner will kick-off summer with a glamping-inspired getaway to New York City and campsite experiences sponsored by Grand Design RV all summer long MIDDLEBURY, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- To celebrate the , Grand Design RV, a wholly owned subsidiary of Winnebago Industries (NYSE: WGO) and one of the fastest-growing RV brands known for its top-of-the-line recreational vehicles, is bringing camping to the heart of New York City this summer by offering one lucky winner the Ultimate Glamping Getaway Weekend, plus a summer fi...

 PRESS RELEASE

Lantheus Announces Executive Appointments to Accelerate Innovation

Lantheus Announces Executive Appointments to Accelerate Innovation Jeffrey S. Humphrey, MD appointed Chief Medical Officer;Jean-Claude Provost, MD named Chief Science Officer BEDFORD, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Jeffrey S. Humphrey, MD has been appointed Chief Medical Officer (CMO) and Jean-Claude Provost, MD has been named Chief Science Officer (CSO), effecti...

 PRESS RELEASE

CooperCompanies to Participate in the Jefferies Global Healthcare Conf...

CooperCompanies to Participate in the Jefferies Global Healthcare Conference SAN RAMON, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 1:30 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at . About CooperCompanies CooperComp...

 PRESS RELEASE

CooperCompanies to Participate in the William Blair Growth Stock Confe...

CooperCompanies to Participate in the William Blair Growth Stock Conference SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled at 11:00 AM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at . About CooperCompanies CooperCompanies (Nasdaq: COO) ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch